RADX Radiopharm Theranostics Limited
$2.44
Radiopharm Theranostics Limited (RADX) is expected to report earnings on July 29, 2025, before the market open. The consensus earnings estimate is a loss of $0.01 per share.
Earnings Date
4th Quarter, Jun 2026
Jul 29
Tuesday · Before Open
Earnings Whisper
-
vs ($0.01)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Radiopharm Theranostics Limited
Radiopharm Theranostic is a clinical-stage biopharmaceutical company focused on developing oncology radiopharmaceuticals for areas of high unmet medical need. Radiopharm Theranostic is based in SYDNEY.
Sector
Healthcare
Industry
Biotechnology